Literature DB >> 24119190

Ulcerated necrobiosis lipoidica as a rare cause for chronic leg ulcers: case report series of ten patients.

Cindy Franklin1, Maren Stoffels-Weindorf1, Uwe Hillen1, Joachim Dissemond1.   

Abstract

Necrobiosis lipoidica is a rare granulomatous disorder of the skin. In up to 30% of the affected patients it can lead to ulcerations, which can impair the quality of life and are also very difficult to treat. Its pathogenesis is not fully understood. Only few studies focussing on necrobiosis lipoidica can be found, but none of them focus on ulcerated necrobiosis lipoidica. Therefore, we collected demographic data and comorbidities and assessed treatment options for patients with ulcerated necrobiosis lipoidica. Data of patients who were treated in the wound care centre of the University Hospital of Essen for ulcerated necrobiosis lipoidica over the past 10 years were retrospectively analysed. Hence, data of altogether ten patients (nine women and one man) with ulcerated necrobiosis lipoidica were collected. Of these, 70% of the patients had diabetes mellitus of which 30% had type I diabetes and 40% had type II diabetes; 60% of the patients suffered from arterial hypertension, obesity and hypercholesterolaemia; 40% of the patients suffered from psychiatric disorders such as depression and borderline disorder. Our clinical data demonstrate an association of ulcerated necrobiosis lipoidica and aspects of metabolic syndrome. This leads to a conclusion that ulcerating necrobiosis lipoidica can be seen as part of a generalised inflammatory reaction similar to the inflammatory reaction already known in the pathophysiology of rheumatoid diseases or psoriasis. In patients with clinical atypical painful ulcerations, necrobiosis lipoidica should be considered as a possible differential diagnosis. Therapists should be aware of associated aspects in patients with ulcerated necrobiosis lipoidica who besides diabetes often suffer from other aspects of a metabolic syndrome with increased cardiovascular risk factors. Therefore, these related comorbidities should also be diagnosed and treated.
© 2013 The Authors. International Wound Journal © 2013 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Chronic wound; Diabetes mellitus; Leg ulcer; Metabolic syndrome; Necrobiosis lipoidica

Mesh:

Year:  2013        PMID: 24119190      PMCID: PMC7950577          DOI: 10.1111/iwj.12159

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  43 in total

1.  Treatment of ulcerated necrobiosis lipoidica with intravenous immunoglobulin and methylprednisolone.

Authors:  Jonathan M Batchelor; Pamela M Todd
Journal:  J Drugs Dermatol       Date:  2012-02       Impact factor: 2.114

Review 2.  Necrobiosis lipoidica.

Authors:  M H Lowitt; J S Dover
Journal:  J Am Acad Dermatol       Date:  1991-11       Impact factor: 11.527

3.  Treatment of pre-ulcerative necrobiosis lipoidica with infliximab.

Authors:  Héléne Conte; Brigitte Milpied; Mamadou Kaloga; Nathalie Lalanne; Emilie Belin; Thomas Jouary; Alain Taieb; Khaled Ezzedine
Journal:  Acta Derm Venereol       Date:  2011-09       Impact factor: 4.437

4.  Squamous cell carcinoma arising in long-standing necrobiosis lipoidica.

Authors:  M Clement; R Guy; A C Pembroke
Journal:  Arch Dermatol       Date:  1985-01

5.  Necrobiosis lipoidica: only a minority of patients have diabetes mellitus.

Authors:  E A O'Toole; U Kennedy; J J Nolan; M M Young; S Rogers; L Barnes
Journal:  Br J Dermatol       Date:  1999-02       Impact factor: 9.302

6.  [A new topically applied morphine gel for the pain treatment in patients with chronic leg ulcers: first results of a clinical investigation].

Authors:  L Huptas; N Rompoti; S Herbig; A Körber; J Klode; D Schadendorf; J Dissemond
Journal:  Hautarzt       Date:  2011-04       Impact factor: 0.751

7.  Cutaneous manifestations of Crohn's disease, its spectrum, and its pathogenesis: intracellular consensus bacterial 16S rRNA is associated with the gastrointestinal but not the cutaneous manifestations of Crohn's disease.

Authors:  A Neil Crowson; Gerard J Nuovo; Martin C Mihm; Cynthia Magro
Journal:  Hum Pathol       Date:  2003-11       Impact factor: 3.466

8.  Ulcerating necrobiosis lipoidica effectively treated with pentoxifylline.

Authors:  K C Noz; M J Korstanje; B J Vermeer
Journal:  Clin Exp Dermatol       Date:  1993-01       Impact factor: 3.470

Review 9.  ["TRECID", TNFalpha related chronic inflammatory diseases - a new multiple diseases bridging concept].

Authors:  U Müller-Ladner; R Alten; A Heiligenhaus; J Kekow; S Koletzko; U Mrowietz; T Ochsenkühn; M Radke; K Reich; M Rudwaleit; S Schreiber
Journal:  Dtsch Med Wochenschr       Date:  2009-10-06       Impact factor: 0.628

10.  Venous insufficiency in patients with necrobiosis lipoidica.

Authors:  Takeshi Nakajima; Atsushi Tanemura; Shigeki Inui; Ichiro Katayama
Journal:  J Dermatol       Date:  2009-03       Impact factor: 4.005

View more
  2 in total

1.  Ulcerative necrobiosis lipoidica diabeticorum successfully treated with topical sevoflurane and punch grafting.

Authors:  Lucía Quintana-Castanedo; Lorena Recarte-Marín; Laura Pérez-Jerónimo; Elena Conde-Montero; Pablo de la Cueva-Dobao
Journal:  Int Wound J       Date:  2019-08-14       Impact factor: 3.315

2.  Unmet challenges in treating hypertension in patients with borderline personality disorder: A systematic review.

Authors:  Saara M Roininen; Marcus Cheetham; Beatrice U Mueller; Edouard Battegay
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.